Jonghoon Choi

Glycosylation is closely related to cellular metabolism and disease progression. In particular, glycan levels in cancer cells and tissues increase during cancer progression. This upregulation of glycosylation in cancer cells may provide a basis for the development of new biomarkers for the targeting and diagnosis of specific cancers. Here, they developed a detection technology for pancreatic cancer cell‐derived small extracellular vesicles (PC‐sEVs) based on lectin–glycan interactions. Lectins specific for sialic acids are conjugated to Janus nanoparticles to induce interactions with PC‐sEVs in a dielectrophoretic (DEP) system. PC‐sEVs are selectively bound to the lectin‐conjugated Janus nanoparticles (lectin–JNPs) with an affinity comparable to that of conventionally used carbohydrate antigen 19‐9 (CA19‐9) antibodies. Furthermore, sEVs‐bound Lectin–JNPs (sEVs‐Lec‐JNPs) are manipulated between two electrodes to which an AC signal is applied for DEP capture. In addition, the proposed DEP system can be used to trap the sEVs–Lec–JNP on the electrodes. Their results, which are confirmed by lectin–JNPs using the proposed DEP system followed by target gene analysis, provide a basis for the development of a new early diagnostic marker based on the glycan characteristics of PC‐sEVs. In turn, these novel detection methods could overcome the shortcomings of commercially available pancreatic cancer detection techniques.